NCT04866108 2022-08-18
A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy
Beijing Friendship Hospital
Phase 2 Unknown
Clinical Trials
3 trialsNCT05068206 2021-10-20
A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Unknown
NCT04160416 2019-11-19
TRICAP
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown